Are you Dr. Reungwetwattana?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Office
Elm St
# Elm
Buffalo, NY 14263Phone+1 716-845-4101Fax+1 716-845-3423
Publications & Presentations
PubMed
- 160 citationsAlectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study.Caicun Zhou, Sang We Kim, Thanyanan Reungwetwattana, Jianying Zhou, Yiping Zhang
The Lancet. Respiratory Medicine. 2019-05-01 - 191 citationsScientific Advances in Lung Cancer 2015Anne S. Tsao, Giorgio V. Scagliotti, Paul A. Bunn, David P. Carbone, Graham W. Warren
Journal of Thoracic Oncology. 2016-05-01 - 32 citationsA phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumorsNuttapong Ngamphaiboon, Grace K. Dy, Wen Wee Ma, Yujie Zhao, Thanyanan Reungwetwattana
Investigational New Drugs. 2015-02-01
